Company · CIK 2019410

# Caris Life Sciences, Inc.

| CIK | [2019410](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002019410) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | TX |
| Business address | TX |
| Listed | CAI (Nasdaq) |
| First annual or quarterly report | 2025-08-12 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-287551 | IPO Final prospectus | 2025-05-23 | 2025-06-20 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-06-20 | [424B4](https://www.sec.gov/Archives/edgar/data/2019410/000110465925060762/0001104659-25-060762-index.htm) Final prospectus | 333-287551 | 0001104659-25-060762 |
| 2025-06-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2019410/999999999525001946/9999999995-25-001946-index.htm) Declared effective | 333-287551 | 9999999995-25-001946 |
| 2025-06-16 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2019410/000110465925059635/0001104659-25-059635-index.htm) Amendment | 333-287551 | 0001104659-25-059635 |
| 2025-06-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2019410/000110465925057593/0001104659-25-057593-index.htm) Amendment | 333-287551 | 0001104659-25-057593 |
| 2025-05-23 | [S-1](https://www.sec.gov/Archives/edgar/data/2019410/000110465925052381/0001104659-25-052381-index.htm) Registration filed | 333-287551 | 0001104659-25-052381 |
| 2024-06-10 | [DRS](https://www.sec.gov/Archives/edgar/data/2019410/000110465924069897/0001104659-24-069897-index.htm) Draft made public | 377-07265 | 0001104659-24-069897 |

[All filings of this company](https://equitycapital.markets/filings?cik=2019410) · [CSV](https://equitycapital.markets/filings.csv?cik=2019410)

---
Source page: https://equitycapital.markets/company/2019410 · Data: U.S. SEC EDGAR · CC BY 4.0